scholarly journals Catheter ablation for atrial fibrillation in patients with end‐stage heart failure and eligibility for heart transplantation

2020 ◽  
Author(s):  
Christian Sohns ◽  
Nassir F. Marrouche ◽  
Angelika Costard‐Jäckle ◽  
Samuel Sossalla ◽  
Leonard Bergau ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Catheter Ablation ◽  
Heart Transplantation ◽  
End Stage Heart Failure ◽  
End Stage

170 Heart Transplantation in 11 Patients with End Stage Heart Failure Caused by Muscular Dystrophy

2012 ◽  
Vol 31 (4) ◽  
pp. S66
Author(s):  
U. Fuchs ◽  
U. Schulz ◽  
B. Schulze ◽  
A. Zittermann ◽  
K. Hakim-Meibodi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Muscular Dystrophy ◽  
Heart Transplantation ◽  
End Stage Heart Failure ◽  
End Stage

Deloading of the Left Ventricle by Ventricular Assist Device Normalizes Increased Expression of Endothelin ET A Receptors But Not Endothelin-Converting Enzyme-1 in Patients With End-Stage Heart Failure

Circulation ◽  
2000 ◽  
Vol 102 (suppl_3) ◽  
Author(s):  
Henning Morawietz ◽  
Marten Szibor ◽  
Winfried Goettsch ◽  
Babett Bartling ◽  
Matthias Barton ◽  
...  
Keyword(s):  
Heart Failure ◽  
Heart Transplantation ◽  
Ace Inhibitor ◽  
Ventricular Myocardium ◽  
Left Ventricular ◽  
Left Ventricular Myocardium ◽  
Converting Enzyme ◽  
Ventricular Assist ◽  
End Stage Heart Failure ◽  
End Stage

Background —Ventricular assist devices (VAD) are implanted in patients with end-stage heart failure for bridging the time until heart transplantation, resulting in hemodynamic unloading of the failing heart, improved cardiac contractile and mitochondrial function, and reversal of cardiac hypertrophy. It is unknown whether VAD unloading may affect the cardiac endothelin (ET) system, which has been proposed as one of the putative pathomechanisms of heart failure. Methods and Results —With the use of standard-calibrated, competitive reverse-transcription–polymerase chain reaction mRNA expression of components of the ET system was analyzed in left ventricular myocardium from nonfailing donor hearts, from failing hearts without and with ACE inhibitor therapy, and from patients with end-stage heart failure at the time of VAD implantation and 103±15 days after VAD implantation during removal with subsequent heart transplantation. ET receptor A (ET A ) was markedly upregulated in failing human myocardium. This increased ET A expression was not affected by ACE inhibitor treatment but was normalized by VAD unloading. ET A expression before or after VAD implantation did not correlate with duration of VAD implantation or suppression of Pro-ANP mRNA. ET B mRNA expression was unaffected by heart failure or VAD. In contrast, increased ET-converting enzyme-1 mRNA and ET-1 peptide levels in failing myocardium were partially normalized by ACE inhibition but not by VAD unloading. Conclusions —We conclude that VAD implantation normalizes ET A expression in failing human left ventricular myocardium, probably as the result of the beneficial effects of VAD unloading.

Heart Transplantation for End-Stage Heart Failure Due to Cardiac Sarcoidosis

2013 ◽  
Vol 45 (6) ◽  
pp. 2384-2386 ◽  
Author(s):  
D. Perkel ◽  
L.S.C. Czer ◽  
R.P. Morrissey ◽  
A. Ruzza ◽  
M. Rafiei ◽  
...  
Keyword(s):  
Heart Failure ◽  
Heart Transplantation ◽  
Cardiac Sarcoidosis ◽  
End Stage Heart Failure ◽  
End Stage

scholarly journals Medium term results following heart transplantation for end stage heart failure: A single center experience of 257 patients

2020 ◽  
Vol 72 (6) ◽  
pp. 524-534
Author(s):  
K.R. Balakrishnan ◽  
K.G. Sureshrao ◽  
R. Ravikumar ◽  
T. Muralikrishna ◽  
K. Ganapathy Subramaniam ◽  
...  
Keyword(s):  
Heart Failure ◽  
Heart Transplantation ◽  
Single Center ◽  
Medium Term ◽  
Single Center Experience ◽  
End Stage Heart Failure ◽  
End Stage

Tubulointerstitial disease is a common finding in biopsy specimens of end-stage heart failure patients awaiting heart transplantation

2014 ◽  
Vol 33 (4) ◽  
pp. 446-448
Author(s):  
Ladan Golestaneh ◽  
Priya P. Deshpande ◽  
Coral Parikh ◽  
Sandipani Sandilya ◽  
James M. Pullman
Keyword(s):  
Heart Failure ◽  
Heart Transplantation ◽  
Common Finding ◽  
Heart Failure Patients ◽  
Biopsy Specimens ◽  
End Stage Heart Failure ◽  
End Stage

Tu1038 Interferon-Free Hepatitis C Treatment in LVAD Patients With End-Stage Heart Failure: New Hope for Heart Transplantation

2015 ◽  
Vol 148 (4) ◽  
pp. S-1092
Author(s):  
Dawn A. Fishbein ◽  
Alexander Geboy ◽  
Maria Elena Ruiz ◽  
Steven W. Boyce ◽  
Ezequiel Molina ◽  
...  
Keyword(s):  
Heart Failure ◽  
Hepatitis C ◽  
Heart Transplantation ◽  
Hepatitis C Treatment ◽  
End Stage Heart Failure ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document